Efficacy and safety of rimonabant for improvement of multiple cardiometabolic risk factors in overweight/obese patients: pooled 1-year data from the Rimonabant in Obesity (RIO) program.

Diabetes care

Volumn 31 Suppl 2, Issue , 2008, Pages

  Van Gaal, Luc ^a   Pi Sunyer, Xavier ^a   Després, Jean Pierre ^a   McCarthy, Christine ^a   Scheen, André ^a  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID; CANNABINOID RECEPTOR; PIPERIDINE DERIVATIVE; PYRAZOLE DERIVATIVE; RIMONABANT;

ANIMAL; ARTICLE; CARDIOVASCULAR DISEASE; DISEASE MODEL; DRUG ANTAGONISM; EXERCISE; HEART DISEASE; HUMAN; LOW CALORY DIET; METABOLIC DISORDER; MULTICENTER STUDY; OBESITY; RISK FACTOR; SAFETY;

ANIMALS; CANNABINOIDS; CARDIOVASCULAR DISEASES; DIET, REDUCING; DISEASE MODELS, ANIMAL; EXERCISE; HEART DISEASES; HUMANS; METABOLIC DISEASES; MULTICENTER STUDIES AS TOPIC; OBESITY; OVERWEIGHT; PIPERIDINES; PYRAZOLES; RECEPTORS, CANNABINOID; RISK FACTORS; SAFETY;

MLCS; MLOWN;

EID: 41149130137     PISSN: None     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc08-s258     Document Type: Article

References (0)